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INTRODUCTION
Maternal Mortality and Perinatal Mortality in Indo-
nesia is still very high. According to the 2007 SDKI
survey data, Indonesia’s maternal mortality rate
was 228 per 100,000 live births, which is still the
highest maternal mortality rate in Asia.1 In addi-
tion to hemorrhage, the major cause of maternal
death in Indonesia at this time is preeclampsia. Ac-
cording to the 2007 report by National Develop-
ment Body (Bapenas), preeclampsia-eclampsia
causes 25% of maternal deaths in Indonesia and
became the second most common cause of mater-
nal mortality after hemorrhage (30%).1,2
Preeclampsia is a syndrome characterized by in-
creased blood pressure accompanied by prote-
inuria, in pregnant women who previously did not
have hypertension.3 This syndrome usually ap-
pears at the end of the second trimester to the
third trimester of pregnancy. Preeclampsia can
have serious implication for both mother and fe-
tus.4 Minimum criteria of pre-eclampsia is charac-
terized by blood pressure of more than 140/90
mmHg after 20 weeks of gestation accompanied by
proteinuria ≥ 300mg/24hours.5,6
World Health Organization (WHO) stated that
the incidence of preeclampsia is about 0.51 to
38.4%. In Indonesia, the incidence of severe pre-
eclampsia is approximately 3-10%.2 At dr. Soetomo
Hospital, it is reported that in 1990 the perinatal
mortality rate is 7.4% in preeclampsia and eclamp-
sia, and the rate of preeclamsia and eclampsia was
32.3%. In Dr. Mohammad Hoesin Hospital Palem-
bang, the average incidence rate between 2005-
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Objective: To determine the comparison between maternal cystatin
C serum in severe preeclampsia and normal pregnancy.
Method: This was an observational study with cross sectional ana-
lytic approach. The subjects are sixty women with severe pree-
clampsia and normal pregnancy who met inclusion criteria. The ma-
ternal serum level of cystatin C was automatically measured with
Particle Enhanced Nephelometric Assay (PENIA).
Result: Mean serum level of cystatin C in severe preeclampsia was
1.169 ± 0.311 mg/l. Mean serum level of cystatin C in normal preg-
nancy was 0.929 ± 0.166. There was a significant differences be-
tween maternal serum levels of cystatin C in women with severe
preeclampsia compared with women with normal pregnancy.
Conclusion: There was a significant differences between maternal
serum levels of cystatin C in severe preeclampsia compared with
normal pregnancy.
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Abstrak
Tujuan: Mengetahui perbandingan kadar serum cystatin C maternal
pada preeklampsia berat dan hamil normal.
Metode: Studi observasional dengan rancangan cross sectional Enam
puluh sampel penderita preeklampsia dan hamil normal yang me-
menuhi kriteria inklusi, yang berobat di RS Dr. Mohammad Hoesin
Palembang dari Maret 2013 sampai April 2013. Kadar serum cystatin
C maternal diukur secara otomatisasi dengan metode particle-en-
hanced nephelometric assay (PENIA).
Hasil: Rerata kadar cystatin C serum pada preeklampsia berat sebe-
sar 1,169 ± 0,311 mg/l. Rerata kadar cystatin C serum pada hamil nor-
mal sebesar 0,929 ± 0,166. Terdapat perbedaan yang bermakna rerata
kadar cystatin C serum pada preeklampsia berat dibandingkan de-
ngan hamil normal (p=0,001).
Kesimpulan: Terdapat perbedaan bermakna kadar cystatin C serum
pada preekampsia berat dibandingkan dengan hamil normal.
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2009 was 9.9% per year.7 This situation is a chal-
lenge for health workers considering the target set
in 2010 by the Health Department to reduce ma-
ternal mortality to be 125/100.000 live births and
neonatal mortality to be lower l5/1000 live births.
Etiology of preeclampsia is still unknown. There
are several hypotheses to explain the pathogenesis
of preeclampsia. Among others is a theory of ab-
normal placental development, predisposing ma-
ternal constitutional factors placental ischemia, im-
mune maladaptation, and genetic susceptibility.8-14
What considered as important in the development
of preeclampsia theory is incomplete trophoblast
invasion or regarded as abnormal cytotrophoblast
invasion of the maternal spiral arteries, resulting
in inadequate trophoblast perfusion, further
spread of the toxin, endothelial cell dysfunction
and vascular endothelial function imbalance va-
sodepressor maternal.14
In preeclampsia and eclampsia changes in the
anatomy and physiology will occur in various or-
gans such as the hemodynamic system, kidneys,
retina and blood chemistry. Various aspects of bio-
chemistry is closely related to preeclampsia. Con-
ditions of good nutrition before pregnancy play an
important role in preventing preeclampsia. The lat-
est concept of preeclampsia is focused on vascular
endothelial dysfunction as a factor involved in the
pathogenesis of preeclampsia. Free radical involve-
ment in preeclampsia may be associated with en-
dothelial dysfunction. Metabolic effects of lipid per-
oxidation causes an imbalance of prostacyclin and
thromboxane production is characterized by im-
paired blood pressure and coagulation process.11,15
In normal pregnancy glomerular hyperfiltration
in the kidneys, where there was an increase of 40-
60%. Hyperfiltration is caused by the decrease in
oncotic pressure in the capillaries glomerulus. De-
crease of plasma oncotic pressure in the glomeru-
lar capillaries caused by two phenomena: firstly
the result of hypervolemia hemodilution would de-
crease the concentration of protein in the plasma
into the glomerular microcirculation. The second
because of the increase in renal plasma flow. In ad-
dition to the changes that pregnancy will increase
kidney size 1 cm. While LFG in preeclampsia de-
creased from 149 ml/min to 91 ml/min.16
Glomerulus is selective in determining the mo-
lecule to be filtered by size and electrical charge.
Substances with small molecular weight can be
freely through the glomerular membrane so that
these substances have similar concentrations in
plasma.17 Cystatin C has a small molecular size
(13.3 kDa). Levels in serum may reflect glomerular
filtration rate (GFR) in non pregnant women.18 Ray
(2003), cystatin C is the strongest inhibitor of the
extracellular cysteine protease that has the effect
of setting the else protease.19
Increased serum levels of cystatin C in pre-
eclampsia in later pregnancy and due to changes
in the kidney in the regulation of protein. But also
due to the synthesis and secretion of proteins that
increase.20,21 Cystatin C levels in maternal plasma
is a good indicator to determine the beginning and
the degree of severity of preeclampsia. In a study
of the renal biopsy, it was found that the levels of
cystatin C was associated with the degree of change
in the structure of the kidney (glomerular endo-
theliosis) that are characteristic of preeclampsia.
Cystatin C levels are also associated with GFR in
normal pregnancy and preeclampsia and advanced
pregnancy.16,22 Cystatin C is only eliminated
through the kidneys, ie after freely filtered by the
glomerulus. Cystatin C is not secreted by the tu-
bules but entirely resorption and catabolized by tu-
bular. Therefore levels in plasma can describe
LFG.23
Changes in renal morphology in preeclampsia
are characterized by endotheliosis glomerular fil-
tration barrier will prevent, so in preeclampsia GFR
decline. Therefore cystatin C levels in plasma can
be used as a marker of renal morphological
changes and is used as a sign of a transition to a
state of normal pregnancy and severity pre-
eclampsia.20,24
This study aimed to compare the serum cystatin
C levels in severe preeclampsia and normal preg-
nancy.
METHOD
The study population is pregnant women with ≥
37 weeks gestation. Subjects were pregnant wo-
men with gestational age ≥ 37 weeks diagnosed
with severe preeclampsia and normal pregnancy
that came and got treatment in the Department of
Obstetrics and Gynecology Hospital dr. Moh. Hoe-
sin/Faculty of Medicine Sriwijaya University, from
March 2013 to April 2013. The sampling method
was consecutive sampling, determined by the or-
der of arrival of patients who met the inclusion cri-
teria. Inclusion criteria were women diagnosed
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with preeclampsia and normal pregnancy, single
life fetus, ≥ 37 weeks gestational age, willing to join
the study and signed an informed consent sheet.
Exclusion criteria were pregnancy with complica-
tions of other diseases such as kidney disease, liver
disease antepartum hemorrhage, chronic infecti-
ous diseases, diabetes mellitus, and anemia, and
pregnant with a dead fetus in the womb. Examina-
tion of serum cystatin C levels in automation with
particle-enhanced nephelometric immunoassay
(PENIA) methods with reagent N latex cystatin C,
OQNM G13 E0541 (109) with the tools in the labo-
ratory Behring Prospec Nephelometer Prodia Pa-
lembang.
RESULTS AND DISCUSSION
Common characteristics of subjects that were en-
countered in this study suggests that the dis-tribu-
tion of the age of majority in the range of subjects
20-35 years old were 19 subjects (63.3%) in severe
preeclampsia and 25 subjects (83.3%) in normal
pregnant with the most parity is multiparous
where the severe preeclampsia group, there were
12 subjects (40.0%) and 17 normal pregnant sub-
jects (56.7%).
Table 1. Subject Characteristic.
Characteristic
Severe
preeclampsia
(n=30)
Normal
pregnancy
(n=30)
Age (yr)
• <20 2 (6.7) 2 (6.7)
• 20-35 19 (63.3) 25 (83.3)
• ≥ 35 9 (30.0) 3 (10.0)
Parity
• Primipara 9 (30.0) 12 (40.0)
• Multipara 12 (40.0) 17 (56.7)
• Grandemultipara 9 (30.0) 1 (3.3)
Address
• Urban area 15 (50.0) 23 (76.7)
• Rural area 15 (50.0) 7 (23.3)
Graduate from school
• Elementary 5 (16.7) 0 (0.0)
• Junior High 12 (40.0) 6 (20.0)
• Senior High 13 (43.3) 22 (73.3)
• Bachelor degree 0 (0.0) 2 (6.7)
Job
• Housewife 22 (73.3) 28 (93.4)
• Labour 4 (13.3) 0 (0.0)
• Farmer 3 (10.0) 0 (0.0)
• Private employee 0 (0.0) 1 (3.3)
• Government employee 0 (0.0) 1 (3.3)
• Trade 1 (3.3) 0 (0.0)
Mean systolic and diastolic blood pressure se-
vere preeclampsia group was higher than the nor-
mal pregnant group 166.3 ± 10.33 and 105.33 ±
6.81 mmHg versus 116.00 ± 8.94 mmHg and 75.67
± 5.68 mmHg and there are significant differences
in systolic and diastolic blood pressure in both
groups (p = 0.000). This result is in line with re-
search by Kristensen et al which found significant
differences in systolic and diastolic blood pressure
between preeclampsia compared with normal
pregnancy (p<0.001) with a mean systolic and dia-
stolic blood pressure at preeclampsia was 151 ± 14
and 100 ± 7 mmHg and the normal pregnant 118
± 12 and 70 ± 9 mmHg.
Table 2. Subject Characteristic.
Characteristic
Severe
preeclampsia
(mean±SD)
Normal
pregnancy
(mean±SD)
Systolic blood
pressure (mmHg)*
166.3±10.33 116.0±8.94
Systolic blood
pressure (mmHg)*
105.33±6.81 75.67±5.68
Level of cystatin
C (mg/l)**
1.169±0.311 0.929±0.166
p=0.000*, p=0.001**
Test results obtained mean levels of Cystatin C,
Cystatin C levels higher severe preeclampsia group
compared with the normal pregnant group is 1.169
± 0.311 mg/l versus 0.929 ± 0.166 mg/l and there
is a significant difference (p = 0.001).
In this study also found a significant association
between cystatin C levels with Means Arterial Pres-
sure with correlation coefficient of 0.460. However,
this correlation suggests that the relationship bet-
ween Cystatin C with moderate MAP. The coeffi-
cient of determination (r2) of 0.212 means that
Cystatin C can be said to have an influence only
21.2% to 78.8% while the MAP is influenced by
other factors (Figure 1).
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DISCUSSION
Common characteristics of subjects that were en-
countered in this study suggests that the distribu-
tion of the age of majority in the range of subjects
20-35 years old were 19 subjects (63.3%) in severe
preeclampsia and 25 subjects (83.3%) in normal
pregnant with the most parity is multiparous
where the severe preeclampsia group, there were
12 subjects (40.0%) and 17 normal pregnant sub-
jects (56.7%). Distribution characteristics of this
age are not much different from the research done
on Kristensen K et al Cystatin C, ß-2 microglobulin
and ß-trace protein in preeclampsia, the mean age
of study subjects obtained was 32 ± 4 years.25 In
Strevens H et al study of serum cystatin C to assess
GFR in pregnant and non-pregnant women fol-
lowed by many women with an average age of 29
± 5 years.20
On the characteristics of parity, it seems that
there are many groups of severe preeclampsia in
multiparous, this is different to that reported Sibai
and Cunningham (2009) from various review stu-
dies around the world that the incidence of pre-
eclampsia in primiparous.8 The difference is pro-
bably due to the research this cross sectional study
period between March and April 2013 in which the
research subjects who met the inclusion criteria
are mostly multiparous.
Mean systolic and diastolic blood pressure se-
vere preeclampsia group was higher than the nor-
mal pregnant group 166.3 ± 10.33 and 105.33 ±
6.81 mmHg versus 116.00 ± 8.94 mmHg and 75.67
± 5.68 mmHg and there are significant differences
in systolic and diastolic blood pressure in both
groups (p = 0.000). This result is in line with re-
search by Kristensen et al which found significant
differences in systolic and diastolic blood pressure
between preeclampsia compared with normal
pregnancy (p<0.001) with a mean systolic and dia-
stolic blood pressure at preeclampsia was 151 ± 14
and 100 ± 7 mmHg and the normal pregnant 118
± 12 and 70 ± 9 mmHg.
Test results obtained mean levels of Cystatin C,
Cystatin C levels higher severe preeclampsia group
compared with the normal pregnant group is 1.169
± 0.311 mg/l versus 0.929 ± 0.166 mg/l and there
is a significant difference (p = 0.001). Results of this
study are in line with previous research conducted
by Strevens H et al who conducted a study on cys-
tatin C were followed 36 preeclamptic women and
12 normal pregnant which found significant differ-
ences (p<0.0001).22 Similarly, research conducted
by Kristensen et al25,26, Yeni CM27, reported signifi-
cant differences in preeclampsia compared with
normal pregnancy.
Based on the statistical analysis we did, found a
significant effect of Cystatin C levels with incident
severe preeclampsia (p = 0.005). Changes in renal
morphology in preeclampsia are characterized by
endotheliosis glomerular filtration barrier will pre-
vent, so in preeclampsia GFR decline. Substances
with small molecular weight, including Cystatin C
may be freely through the glomerular membrane.
Cystatin C is not secreted by the tubules but en-
tirely resorption and catabolized by the tubules, so
that levels in plasma can describe LFG.23 Therefore
change the filtration barrier is an increase in Cys-
tatin C levels in severe preeclampsia. Strevens et
al reported the results of research that was fol-
lowed by 36 preeclamptic women and 12 normal
pregnant kidney biopsy is done to determine the
degree of difference endotheliosis. The result is a
serum Cystatin C levels had a significant correla-
tion with the degree of endotheliosis and increased
glomerular volume in pregnancies with preeclamp-
sia (p<0.001).22
In this study also found a significant association
between Cystatin C levels with Means Arterial
Pressure with correlation coefficient of 0.460.
However, this correlation suggests that the rela-
tionship between Cystatin C with moderate MAP.
The coefficient of determination (r2) of 0.212
means that Cystatin C can be said to have an influ-
ence only 21.2% to 78.8% while the MAP is influ-
 
Figure 1. Relationship between Cystatin C and Means Ar-
terial Pressure.
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enced by other factors (Figure 1). This is consistent
with the pathogenesis of preeclampsia is very com-
plex with many factors that are believed to con-
tribute to disease progression such as abnormal
development of the placenta, maternal predispos-
ing factors, oxidative stress, immune maladapta-
tion and genetic factors. Each of these factors play
a role in maternal systemic endothelial dysfunction
that causes vasoconstriction and decreased tissue
and organ perfusion.28
Yanik F et al reported an increase in preeclamp-
sia higher lipid peroxidation, as well as dealing
with increasing bloodpressure.29 In preeclampsia
endothelial damage causing leakage especially in
the micro vascular system. Under normal circum-
stances, endothelial cells produce prostacyclin re-
latively high. While platelets produce thrombo-
xane. If there is damage to the endothelial pros-
tacyclin production will decrease. Instead throm-
boxane increases because of the many platelet ag-
gregation. Consequently prostacyclin-thromboxane
ratio decreased the vasoconstriction, thus the ef-
fect will be greater and causing hypertension.10
CONCLUSIONS
There was a significant differences between ma-
ternal serum levels of Cystatin C in severe pre-
eclampsia compared with normal pregnancy.
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